{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:31:34Z","timestamp":1794652294097,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian Government Medical Research Future Fund","award":["GA187306"],"award-info":[{"award-number":["GA187306"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Emerging Leadership 1 grant (APP2009633)"],"award-info":[{"award-number":["Emerging Leadership 1 grant (APP2009633)"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implementation Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Clinical practice guidelines recommend against the routine use of psychotropic medications in residential aged care facilities (RACFs). Knowledge brokers are individuals or groups who facilitate the transfer of knowledge into practice. The objective of this trial is to evaluate the effectiveness and cost-effectiveness of using knowledge brokers to translate Australia\u2019s new Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The Evidence-based Medication knowledge Brokers in Residential Aged CarE (EMBRACE) trial is a helix-counterbalanced randomised controlled trial. The 12-month trial will be conducted in up to 19 RACFs operated by four Australian aged care provider organisations in Victoria, New South Wales, Western Australia and Queensland. RACFs will be randomised to receive three levels of implementation strategies (knowledge broker service, pharmacist-led quality use of medications education activities and distribution of the Guidelines and supporting materials) across three medication contexts (antipsychotics, benzodiazepines and antidepressants). Implementation strategies will be delivered by an embedded on-site aged care pharmacist working at a system level across each participating RACF. All RACFs will receive all implementation strategies simultaneously but for different medication contexts. The primary outcome will be a composite dichotomous measure of 6-month RACF-level concordance with Guideline recommendations and good practice statements among people using antipsychotics, benzodiazepines and antidepressants for changed behaviours. Secondary outcomes will include proportion of residents with Guideline concordant use of antipsychotics, benzodiazepines and antidepressants measured at the RACF-level and proportion of residents with psychotropic medication use, hospitalisation, falls, falls with injury, polypharmacy, quality of life, activities of daily living, medication incidents and behavioural incidents measured at the RACF-level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The EMBRACE trial investigates a novel guideline implementation strategy to improve the safe and effective use of psychotropic medications in RACFs. We anticipate that the findings will provide new information on the potential role of knowledge brokers for successful and cost-effective guideline implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12623001141639. Registered 6 November 2023 \u2014 retrospectively registered,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/TrialSearch.aspx\">https:\/\/www.anzctr.org.au\/TrialSearch.aspx<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13012-024-01353-z","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T10:01:46Z","timestamp":1709546506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evidence-based Medication knowledge Brokers in Residential Aged CarE (EMBRACE): protocol for a helix-counterbalanced randomised controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"J. Simon","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"La Caze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Steeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry P.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah N.","family":"Hilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakkhina","family":"Troeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyntara","family":"Quirke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Wesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance Dimity","family":"Pond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Buys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Ghahreman-Falconer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Lawless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakti","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelita","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Ochieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Glamorgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Lagasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayna","family":"Cenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Kitson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6001-9211","authenticated-orcid":false,"given":"Amanda J.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"issue":"2","key":"1353_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0004867418758919","volume":"53","author":"J Westbury","year":"2019","unstructured":"Westbury J, Gee P, Ling T, Kitsos A, Peterson G. More action needed: psychotropic prescribing in Australian residential aged care. Aust N Z J Psychiatry. 2019;53(2):136\u201347.","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"1353_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40801-017-0121-x","volume":"4","author":"N Jokanovic","year":"2017","unstructured":"Jokanovic N, Jamsen KM, Tan ECK, Dooley MJ, Kirkpatrick CM, Bell JS. Prevalence and variability in medications contributing to polypharmacy in long-term care facilities. Drugs Real World Outcomes. 2017;4(4):235\u201345.","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"1353_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1176\/appi.ajp.2015.173501","volume":"173","author":"VI Reus","year":"2016","unstructured":"Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD, et al. The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am J Psychiatry. 2016;173(5):543\u20136.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"1353_CR4","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/ene.14412","volume":"27","author":"KS Frederiksen","year":"2020","unstructured":"Frederiksen KS, Cooper C, Frisoni GB, Fr\u00f6lich L, Georges J, Kramberger MG, et al. A European Academy of Neurology guideline on medical management issues in dementia. Eur J Neurol. 2020;27(10):1805\u201320.","journal-title":"Eur J Neurol"},{"key":"1353_CR5","unstructured":"Guideline Adaptation Committee. Clinical practice guidelines and principles of care for people with dementia. Sydney. Guideline Adaptation Commitee; 2016. Available from: https:\/\/cdpc.sydney.edu.au\/wp-content\/uploads\/2019\/06\/CDPC-Dementia-Guidelines_WEB.pdf. Accessed 7 Dec 2023."},{"issue":"12","key":"1353_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2011.1360","volume":"306","author":"AR Maher","year":"2011","unstructured":"Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306(12):1359\u201369.","journal-title":"JAMA"},{"issue":"Supplement 1","key":"1353_CR7","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1093\/schbul\/sby016.282","volume":"44","author":"J Schneider-Thoma","year":"2018","unstructured":"Schneider-Thoma J, Leucht S. Second generation antipsychotic drugs and mortality: a meta-analysis of placebo-controlled randomised controlled trials. Schizophr Bull. 2018;44(Supplement 1):S115.","journal-title":"Schizophr Bull"},{"issue":"4","key":"1353_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174730","volume":"12","author":"K Donnelly","year":"2017","unstructured":"Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS ONE. 2017;12(4): e0174730.","journal-title":"PLoS ONE"},{"key":"1353_CR9","doi-asserted-by":"crossref","unstructured":"Seppala LJ, Wermelink AMAT, de Vries M, Ploegmakers KJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371.e11-.e17.","DOI":"10.1016\/j.jamda.2017.12.098"},{"issue":"8","key":"1353_CR10","first-page":"Cd003944","volume":"8","author":"R Dudas","year":"2018","unstructured":"Dudas R, Malouf R, McCleery J, Dening T. Antidepressants for treating depression in dementia. Cochrane Database Syst Rev. 2018;8(8):Cd003944.","journal-title":"Cochrane Database Syst Rev."},{"key":"1353_CR11","unstructured":"Tracey R, Briggs L. Royal commission into aged care quality and safety: interim report. 2019. Available from: https:\/\/www.royalcommission.gov.au\/system\/files\/2021-03\/interim-report-volume-1.pdf. Accessed 7 Dec 2023."},{"key":"1353_CR12","unstructured":"Simon Bell RB, Sue Brennan, Malcolm Clark, Megan Corlis, Christopher Etherton-Beer, Susan Field, et al (Guideline Development Group). Clinical practice guidelines for the appropriate use of psychotropic medications in people living with dementia and in residential aged care: summary of recommendations and good practice statements. Parkville: Monash University 2022. Available from: https:\/\/app.magicapp.org\/#\/guideline\/jMMeqj. Accessed 7 Dec 2023."},{"issue":"3","key":"1353_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.15171\/ijhpm.2017.79","volume":"7","author":"A Kitson","year":"2018","unstructured":"Kitson A, Brook A, Harvey G, Jordan Z, Marshall R, O\u2019Shea R, et al. Using complexity and network concepts to inform healthcare knowledge translation. Int J Health Policy Manag. 2018;7(3):231\u201343.","journal-title":"Int J Health Policy Manag"},{"issue":"5","key":"1353_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.15171\/ijhpm.2017.15","volume":"6","author":"A Kothari","year":"2017","unstructured":"Kothari A, McCutcheon C, Graham ID. Defining integrated knowledge translation and moving forward: a response to recent commentaries. Int J Health Policy Manag. 2017;6(5):299\u2013300.","journal-title":"Int J Health Policy Manag"},{"key":"1353_CR15","unstructured":"World Health Organization. Medication without harm. Available from: https:\/\/www.who.int\/initiatives\/medication-without-harm. Accessed 7 Dec 2023."},{"issue":"5","key":"1353_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/bmjqs-2022-015595","volume":"32","author":"AJ Cross","year":"2023","unstructured":"Cross AJ, Haines TP, Ooi CE, La Caze A, Karavesovska S, Lee EJ, et al. Roles and effectiveness of knowledge brokers for translating clinical practice guidelines in health-related settings: a systematic review. BMJ Qual Saf. 2023;32(5):286\u201395.","journal-title":"BMJ Qual Saf"},{"issue":"4","key":"1353_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/jppr.1821","volume":"52","author":"AJ Cross","year":"2022","unstructured":"Cross AJ, La Caze A, Steeper M, Bell JS. Embedding pharmacists in residential aged care: why it\u2019s important to integrate resident- and system-level services. J Pharm Pract Res. 2022;52(4):263\u20135.","journal-title":"J Pharm Pract Res"},{"key":"1353_CR18","unstructured":"Australian Commission on Safety and Quality in Health Care. National baseline report on quality use of medicines and medicines safety \u2013 phase 1: residential aged care. Sydney: ACSQHC; 2021. Available from: https:\/\/www.safetyandquality.gov.au\/sites\/default\/files\/2022-02\/qum_and_medicines_safety-10th_national_hority_-_national_baseline_report_phase_i_residential_aged_care_-_accessible_pdf.pdf. Accessed 7 Dec 2023."},{"issue":"1","key":"1353_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13012-019-0896-0","volume":"14","author":"MN Sarkies","year":"2019","unstructured":"Sarkies MN, Skinner EH, Bowles KA, Morris ME, Williams C, O\u2019Brien L, et al. A novel counterbalanced implementation study design: methodological description and application to implementation research. Implement Sci. 2019;14(1):45.","journal-title":"Implement Sci"},{"key":"1353_CR20","doi-asserted-by":"publisher","unstructured":"La Caze A, Shrestha S, Cross AJ, Steeper M, Ghrahreman-Falconer N, Buys L, et al. Ensuring appropriate use of psychotropic medicines in residential aged care: the people, processes and infrastructure (Poster). 81st FIP World Congress of Pharmacy and Pharmaceutical Sciences in Brisbane, Australia, 24\u201328 September 2023. Pharmacy Education. 2023;23(6)435\u2013509. Available from: https:\/\/doi.org\/10.46542\/pe.2023.236.435509. Accessed 7 Dec 2023.","DOI":"10.46542\/pe.2023.236.435509"},{"key":"1353_CR21","first-page":"1","volume":"00","author":"AJ Cross","year":"2023","unstructured":"Cross AJ, Bell JS, Steeper M, La Caze A. Embedded on-site aged care pharmacists in Australia: insights from early adopters of a new workforce model. Australas J Ageing. 2023;00:1\u201312.","journal-title":"Australas J Ageing"},{"issue":"3","key":"1353_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2014.12.013","volume":"16","author":"AM Sanford","year":"2015","unstructured":"Sanford AM, Orrell M, Tolson D, Abbatecola AM, Arai H, Bauer JM, et al. An international definition for \u201cnursing home.\u201d J Am Med Dir Assoc. 2015;16(3):181\u20134.","journal-title":"J Am Med Dir Assoc"},{"key":"1353_CR23","unstructured":"Australian Government Department of Health and Aged Care. About aged care. 2023. Available from: https:\/\/www.health.gov.au\/topics\/aged-care\/about-aged-care#who-is-eligible. Accessed 7 Dec 2023."},{"key":"1353_CR24","unstructured":"Australian Institute of Health and Welfare. People using aged care. Canberra: Australian Institute of Health and Welfare, 2022. Available from: https:\/\/www.gen-agedcaredata.gov.au\/topics\/people-using-aged-care. Accessed 7 Dec 2023."},{"key":"1353_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.phrs.2016.12.011","volume":"116","author":"JK Sluggett","year":"2017","unstructured":"Sluggett JK, Ilom\u00e4ki J, Seaman KL, Corlis M, Bell JS. Medication management policy, practice and research in Australian residential aged care: current and future directions. Pharmacol Res. 2017;116:20\u20138.","journal-title":"Pharmacol Res"},{"key":"1353_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346: e7586.","journal-title":"BMJ"},{"issue":"3","key":"1353_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"1353_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ajag.12676","volume":"38","author":"EYH Chen","year":"2019","unstructured":"Chen EYH, Wang KN, Sluggett JK, Ilomaki J, Hilmer SN, Corlis M, et al. Process, impact and outcomes of medication review in Australian residential aged care facilities: a systematic review. Australas J Ageing. 2019;38(Suppl 2):9\u201325.","journal-title":"Australas J Ageing"},{"key":"1353_CR29","unstructured":"Pharmaceutical Society of Australia. Residential aged care pharmacist: foundation training program. Available from: https:\/\/my.psa.org.au\/s\/training-plan\/a110o00000C0UNMAA3\/residential-aged-care-pharmacist-foundation-training-program. Accessed 7 Dec 2023."},{"key":"1353_CR30","unstructured":"Pharmaceutical Society of Australia. Guidelines for quality use of medicines (QUM) services. 2020. Available from: https:\/\/www.ppaonline.com.au\/wp-content\/uploads\/2020\/04\/PSA-Guidelines-for-Quality-Use-of-Medicines-QUM-services.pdf. Accessed 7 Dec 2023."},{"key":"1353_CR31","unstructured":"Australian Government Department of Health and Aged Care. Glossary for the guiding principles and user guide. 2022. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/2022-11\/glossary-for-the-guiding-principles-and-user-guide.pdf. Accessed 7 Dec 2023."},{"key":"1353_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13012-016-0398-2","volume":"11","author":"G Harvey","year":"2016","unstructured":"Harvey G, Kitson A. PARIHS revisited: from heuristic to integrated framework for the successful implementation of knowledge into practice. Implement Sci. 2016;11:33.","journal-title":"Implement Sci"},{"key":"1353_CR33","unstructured":"Australian Government Department of Health and Aged Care. National Aged Care Mandatory Quality Indicator Program (QI Program). 2023. Available from: https:\/\/www.health.gov.au\/our-work\/qi-program. Accessed 7 Dec 2023."},{"key":"1353_CR34","unstructured":"Australian Government Aged Care Quality and Safety Commission. Psychotropic self-assessment tool. 2022. Available from: https:\/\/www.agedcarequality.gov.au\/resources\/self-assessment-tool-psychotropic-medications. Accessed 7 Dec 2023."},{"key":"1353_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95: 103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"1353_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"1353_CR37","unstructured":"Australian Government Department of Health and Aged Care. National Aged Care Mandatory Quality Indicator Program (QI program): Manual 3.0-Part A. 2022. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/2023-11\/national-aged-care-mandatory-quality-indicator-program-manual-3-0-part-a_0.pdf. Accessed 7 Dec 2023."},{"issue":"11","key":"1353_CR38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s40273-022-01158-2","volume":"40","author":"J Ratcliffe","year":"2022","unstructured":"Ratcliffe J, Bourke S, Li J, Mulhern B, Hutchinson C, Khadka J, et al. Valuing the Quality-of-Life Aged Care Consumers (QOL-ACC) instrument for quality assessment and economic evaluation. Pharmacoeconomics. 2022;40(11):1069\u201379.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"1353_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3109\/09638288809164103","volume":"10","author":"C Collin","year":"1988","unstructured":"Collin C, Wade DT, Davies S, Horne V. The Barthel ADL Index: a reliability study. Int Disabil Stud. 1988;10(2):61\u20133.","journal-title":"Int Disabil Stud"},{"issue":"5","key":"1353_CR40","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/jcm10051104","volume":"10","author":"N Dugr\u00e9","year":"2021","unstructured":"Dugr\u00e9 N, Bell JS, Hopkins RE, Ilom\u00e4ki J, Chen EYH, Corlis M, et al. Impact of medication regimen simplification on medication incidents in residential aged care: SIMPLER randomized controlled trial. J Clin Med. 2021;10(5):1104.","journal-title":"J Clin Med"},{"key":"1353_CR41","unstructured":"Australian Government Aged Care Quality and Safety Commission. Serious Incident Response Scheme: guidelines for residential aged care providers. 2022. Available from: https:\/\/www.agedcarequality.gov.au\/sites\/default\/files\/media\/SIRS-guidelines-for-residential-aged-care-providers.pdf. Accessed 7 Dec 2023."},{"issue":"1","key":"1353_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s43058-020-00073-x","volume":"1","author":"K Laver","year":"2020","unstructured":"Laver K, Cations M, Radisic G, de la Perrelle L, Woodman R, Fitzgerald JA, et al. Improving adherence to guideline recommendations in dementia care through establishing a quality improvement collaborative of agents of change: an interrupted time series study. Implement Sci Commun. 2020;1(1):80.","journal-title":"Implement Sci Commun"},{"key":"1353_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-14-15","volume":"14","author":"A Grant","year":"2013","unstructured":"Grant A, Treweek S, Dreischulte T, Foy R, Guthrie B. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials. 2013;14:1.","journal-title":"Trials"},{"key":"1353_CR44","unstructured":"Australian Institute of Health and Welfare. Dementia in Australia. Canberra: Australian Institute of Health and Welfare, 2023. Available from: https:\/\/www.aihw.gov.au\/reports\/dementia\/dementia-in-aus. Accessed 7 Dec 2023."},{"key":"1353_CR45","unstructured":"World Health Organization. Global action plan on the public health response to dementia 2017\u20132025. 2017. Available from: https:\/\/www.who.int\/publications\/i\/item\/global-action-plan-on-the-public-health-response-to-dementia-2017---2025. Accessed 7 Dec 2023."},{"key":"1353_CR46","unstructured":"Australian Government Aged Care Quality and Safety Commission. Aged Care Quality and Safety Commission Annual Report 2018\u201319. 2019. Available from: https:\/\/www.agedcarequality.gov.au\/sites\/default\/files\/media\/ACQSC_AR_2018-19_Full_Final.pdf. Accessed 7 Dec 2023."},{"issue":"6","key":"1353_CR47","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jamda.2020.12.035","volume":"22","author":"IR Wojt","year":"2021","unstructured":"Wojt IR, Cairns R, Clough AJ, Tan ECK. The prevalence and characteristics of psychotropic-related hospitalizations in older people: a systematic review and meta-analysis. J Am Med Dir Assoc. 2021;22(6):1206-14.e5.","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"1353_CR48","doi-asserted-by":"publisher","first-page":"1311 e1- e8","DOI":"10.1016\/j.jamda.2023.06.037","volume":"24","author":"H Almutairi","year":"2023","unstructured":"Almutairi H, Stafford A, Etherton-Beer C, Fitzgerald P, Flicker L. Impact of a multifaceted, pharmacist-led intervention on psychotropic medication use for residents of aged care facilities: a parallel cluster randomized controlled trial. J Am Med Dir Assoc. 2023;24(9):1311 e1-e8.","journal-title":"J Am Med Dir Assoc."},{"issue":"1","key":"1353_CR49","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1332\/174426421X16149632470114","volume":"18","author":"S Chew","year":"2022","unstructured":"Chew S, Armstrong N, Martin GP. Understanding knowledge brokerage and its transformative potential: a Bourdieusian perspective. Evid Policy. 2022;18(1):25\u201342.","journal-title":"Evid Policy"},{"issue":"1","key":"1353_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/chp.20098","volume":"31","author":"D Cameron","year":"2011","unstructured":"Cameron D, Russell DJ, Rivard L, Darrah J, Palisano R. Knowledge brokering in children\u2019s rehabilitation organizations: perspectives from administrators. J Contin Educ Health Prof. 2011;31(1):28\u201333.","journal-title":"J Contin Educ Health Prof"}],"container-title":["Implementation Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-024-01353-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13012-024-01353-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13012-024-01353-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T15:17:09Z","timestamp":1709911029000},"score":1,"resource":{"primary":{"URL":"https:\/\/implementationscience.biomedcentral.com\/articles\/10.1186\/s13012-024-01353-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1186\/s13012-024-01353-z","relation":{},"ISSN":["1748-5908"],"issn-type":[{"value":"1748-5908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial has received Monash University Human Research Ethics Committee approval (ID 35525). The research will be conducted in accordance with the World Medical Association Declaration of Helsinki. The trial evaluates RACF-level interventions, and individual residents will not be recruited to participate. The aged care provider organisations were partners in the application for grant funding. RACF-level consent to participate was obtained from an authorised representative of the aged care provider organisation or RACF manager. If an aged care provider organisation or RACF manager decides to withdraw throughout the trial, data that have been collected prior to withdrawal will be included in the data analysis if permitted. No new data will be collected after the aged care provider organisation or RACF has withdrawn from the trial. Any planned changes in the protocol will be approved by the ethics committee, communicated to relevant stakeholders, and updated in the ANZCTR.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J. S. B. has received grant funding or consulting funds from the National Health and Medical Research Council, Medical Research Future Fund, Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, Yulgilbar Foundation, Aged Care Quality and Safety Commission, Dementia Centre for Research Collaboration, Pharmaceutical Society of Australia, Society of Hospital Pharmacists of Australia, GlaxoSmithKline Supported Studies Programme, Amgen, and several aged care provider organisations unrelated to this work. All grants and consulting funds were paid to the employing institution. J. W. was previously employed at Montefiore Homes and continues to have a professional links with them, including paid mentoring roles. A. J. C. has received grant funding or consulting funds from the Medical Research Future Fund and Pharmaceutical Society of Australia. All grants and consulting funds were paid to the employing institution. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}